China Pharma Holdings (CPHI) Total Debt Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 41.53% |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 | 34.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.16% |
| Dec 31, 2025 | -43.41% |
| Sep 30, 2025 | -20.78% |
| Jun 30, 2025 | 12.36% |
| Mar 31, 2025 | -4.31% |
| Dec 31, 2024 | -0.38% |
| Sep 30, 2024 | 2.46% |
| Jun 30, 2024 | -14.44% |
| Mar 31, 2024 | -18.27% |
| Dec 31, 2023 | 4.29% |
| Sep 30, 2023 | -47.58% |
| Jun 30, 2023 | -12.26% |
| Mar 31, 2023 | -30.63% |
| Dec 31, 2022 | -55.69% |
| Sep 30, 2022 | 187.28% |
| Jun 30, 2022 | 29.74% |
| Mar 31, 2022 | 44.18% |
| Dec 31, 2021 | 87.19% |
| Sep 30, 2021 | 60.00% |
| Jun 30, 2021 | -21.57% |